首页> 外文期刊>Medical science monitor : >Distal Pancreatectomy with en Bloc Celiac Axis Resection for Pancreatic Body-Tail Cancer: Is it Justified?
【24h】

Distal Pancreatectomy with en Bloc Celiac Axis Resection for Pancreatic Body-Tail Cancer: Is it Justified?

机译:胰体尾癌全胰腹腔切除联合远端胰切除术:是否合理?

获取原文
           

摘要

BACKGROUND The aim of this study was to evaluate the safety and efficacy of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) for pancreatic body-tail cancer. MATERIAL AND METHODS The medical records of 12 patients who underwent DP-CAR for pancreatic body-tail cancer were retrospectively studied, together with a literature review of studies including at least 3 cases of DP-CAR. RESULTS There were no deaths among our 12 cases. Postoperative morbidity developed in 9 cases and was successfully managed by non-surgical treatment. No patients developed ischemic complications. Median overall survival was 10 months. A total of 19 studies involving 203 patients who underwent DP-CAR were included in the literature review. The overall morbidity and mortality rates were 50.2% and 3.0%, respectively. The overall median survival after surgery ranged from 9.3 to 26 months. CONCLUSIONS DP-CAR is a safe and effective treatment for patients with locally advanced pancreatic body-tail cancer.
机译:背景技术这项研究的目的是评估采用胰腹腔全切除术(DP-CAR)进行的胰腺远端切除术治疗胰腺尾癌的安全性和有效性。材料与方法回顾性研究了12例行DP-CAR治疗胰腺尾癌的患者的病历,并对包括至少3例DP-CAR的研究进行了文献综述。结果我们的12例病例中没有死亡。 9例发生了术后发病,并且通过非手术治疗得到了成功的治疗。没有患者发生缺血性并发症。中位总生存期为10个月。文献综述共纳入19项研究,涉及203例行DP-CAR的患者。总体发病率和死亡率分别为50.2%和3.0%。手术后的总中位生存期为9.3到26个月。结论DP-CAR对于局部晚期胰腺体尾癌患者是一种安全有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号